Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus - Their association with aneuploidy and neoplastic progression

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 547, Issue 1-2, 2004, Pages 133-144

  Doak, Shareen H ^a   Jenkins, Gareth J S ^a   Parry, Elizabeth M ^a   Griffiths, A Paul ^b   Baxter, John N ^b   Parry, James M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Aneuploidy; Barrett's oesophagus; BUB1; HSP27; MAD2; Mitotic spindle checkpoint

Indexed keywords

BUB1 RELATED PROTEIN; HEAT SHOCK PROTEIN 27; PROTEIN MAD2;

ADENOCARCINOMA; ADULT; AGED; ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; CHROMOSOME; CHROMOSOME SEGREGATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM CANCER; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METAPLASIA; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADENOCARCINOMA; ANEUPLOIDY; BARRETT ESOPHAGUS; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MALE; METAPLASIA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROTEIN KINASES; REPRESSOR PROTEINS; SEX FACTORS;

EID: 1542285499     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.12.009     Document Type: Article

References (55)

1. Fitzgerald R.C., Triadafilopoulos G. Recent developments in the molecular characterisation of Barrett's esophagus. Dign. Dis. 16:1998;63-80.
2. Jenkins G.J.S., Doak S.H., Parry J.M., D'Souza F.R., Griffiths A.P., Baxter J.N. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br. J. Surg. 89:2002;824-837.
3. Doak S.H., Jenkins G.J.S., Parry E.M., D'Souza F.R., Griffiths A.P., Toffazal N., Shah V., Baxter J.N., Parry J.M. Chromosome 4 hyperploidy represents an early genetic aberration in pre-malignant Barrett's oesophagus. Gut. 52:2003;623-629.
4. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
5. Sen S. Aneuploidy and cancer. Curr. Opin. Oncol. 12:2000;82-88.
6. Li R., Murray A.W. Feedback-control of mitosis in budding yeast. Cell. 66:1991;519-531.
7. Hoyt M.A., Totis L., Roberts B.T. Saccharomyces-cerevisiae genes required for cell-cycle arrest in response to loss of microtubule function. Cell. 66:1991;507-517.
8. Millband D.N., Campbell L., Hardwick K.G. The awesome power of multiple model systems: interpreting the complex nature of spindle checkpoint signalling. Trends Cell Biol. 12:2002;205-209.
9. Gemma A., Seike M., Seike Y., Uematsu K., Hibino S., Kurimoto F., Yoshimura A., Shibuya M., Harris C.C., Kudoh S. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer. Genes Chromosomes Cancer. 29:2000;213-218.
10. Ouyang B., Knauf J.A., Ain K., Nacev B., Fagin J.A. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1. Clin. Endocrinol. 56:2002;341-350.
11. Shichiri M., Yoshinaga K., Hisatomi H., Sugihara K., Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 62:2002;13-17.
12. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K.V., Markowitz S.D., Kinzler K.W., Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:1998;300-303.
13. Li Y., Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science. 274:1996;246-248.
14. Wang X., Jin D., Wong Y.C., Cheung A.L.M., Chun A.C.S., Lo A.K.F., Liu Y., Tsao S.W. Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis. 21:2000;2293-2297.
15. Wang X., Jin D., Ng R.W.M., Feng H., Wong Y.C., Cheung A.L.M., Tsao S.W. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62:2002;1662-1668.
16. Michel L.S., Liberal V., Chatterjee A., Kirchwegger R., Pasche B., Gerald W., Dobles M., Sorger P.K., Murty V.V.V.S., Benezra R. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 409:2001;355-359.
17. Soldes O.S., Kuick R.D., Thompson I.A., Hughes S.J., Orringer M.B., Lannettoni M.D., Hanash S.M., Beer D.G. Differential gene expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br. J. Cancer. 79:1999;595-603.
18. Reno C., Marchuk L., Sciore P., Frank C.B., Hart D.A. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. Biotechniques. 22:1997;1082-1086.
19. Applied biosystems. Relative quantitation of gene expression, User Bulletin #2: ABI Prism 7700 Sequence Detection System, 1997.
20. -Δ(ΔCT) method Methods. 25:2001;402-408.
21. Tokunaga E., Maehara Y., Oki E., Kitamura K., Kakeji Y., Ohno S., Sugimachi K. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett. 152:2000;15-22.
22. Chang J.T., Chen I.H., Liao C.T., Wang H.M., Hsu Y.M., Hung K.F., Lin C.J., Hsieh L.L., Cheng A.J. A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients. Clin. Biochem. 35:2001;591-596.
23. Campomenosi P., Assereto P., Bogliolo M., Fronza G., Abbondandolo A., Capasso A., Bellomo P.F., Monaco R., Rapallo A., Sciutto A., Orecchia R., Geido E., Giaretti W. p53 mutations and DNA ploidy in colorectal adenocarcinomas. Anal. Cell. Pathol. 17:1998;1-12.
24. Fukasawa K., Wiener F., Vande Woude G.F., Mai S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene. 15:1997;1295-1302.
25. Haruki N., Harano T., Masuda A., Kiyono T., Takahashi T., Tatematsu Y., Schimizu S., Mitsudomi T., Konishi H., Osada H., Fujii Y., Takahashi T. Persistent increase in chromosome instability in lung cancer - possible indirect involvement of p53 inactivation. Am. J. Pathol. 159:2001;1345-1352.
26. Doak S.H., Jenkins G.J.S., Parry E.M., Griffiths A.P., Shah V., Baxter J.N., Parry J.M. Characterisation of the p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Br. J. Cancer. 89:2003;1729-1735.
27. Gonzalez M.V., Artimez M.L., Rodrigo L., LopezLarrea C., Menendez M.J., Alvarez V., Perez R., Fresno M.F., Perez M.J., Sampedro A., Coto E. Mutation analysis of the p53, APC and p16 genes in the Barrett's oesophagus, dysplasia and adenocarcinomas. J. Clin. Pathol. 50:1997;212-217.
28. Kirsch-Volders M., Vanhauwaert A., De Boeck M., Decordier I., Importance of detecting numerical versus structural chromosome aberrations Mutat. Res. 504:2002;137-148.
29. Pihan G.A., Purohit A., Wallace J., Knecht H., Woda B., Quesenberry P., Doxsey S.J. Centrosome defects and genetic instability in malignant tumours. Cancer Res. 58:1998;3974-3985.
30. Pihan G.A., Purohit A., Wallace J., Malhotra R., Liotta L., Doxsey S.J. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 61:2001;2212-2219.
31. Sato N., Mizumoto K., Nakamura M., Maehara N., Minamishima Y.A., Nishio S., Nagai E., Tanaka M. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet. Cytogenet. 126:2001;13-19.
32. Pihan G.A., Wallace J., Zhou Y., Doxsey S.J. Centrosomal abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 63:2003;1398-1404.
33. Amon A. The spindle checkpoint. Curr. Opin. Genet. Dev. 9:1999;69-75.
34. Cahill D.P., da Costa L.T., Carson-Walter E.B., Kinzler K.W., Vogelstein B., Lengauer C. Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics. 58:1999;181-187.
35. Hernando E., Orlow I., Liberal V., Nohales G., Benezra R., Cordon-Cardo C. Molecular analyses of the mitotic checkpoint components HSMAD2, HBUB1 and HBUB3 in human cancer. Int. J. Cancer. 95:2001;223-227.
36. Gorbsky G.J., Chen R.H., Murray A.W. Microinjection of antibody to MAD2 protein into mammalian cells in mitosis induces premature anaphase. J. Cell Biol. 141:1998;1193-1205.
37. Tanaka K., Nishioka J., Kato K., Nakamura A., Mouri T., Mili C., Kusunok M., Nobori T. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn. J. Cancer Res. 92:2001;952-958.
38. Percy M.J., Myrie K.A., Neeley C.K., Azim J.N., Ethier S.P., Petty E.M. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer. 29:2000;356-362.
39. Reis R.M., Nakamura M., Masuoka J., Watanabe T., Colella S., Yonekawa Y., Kleihues P., Ohgaki H. Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas. Acta Neuropathol. 101:2001;297-304.
40. Nakagawa H., Yokozaki H., Oue N., Sugiyama M., Ishikawa T., Tahara E., Yasui W. No mutations of the Bub1 gene in human gastric and oral cancer cell lines. Oncol. Rep. 9:2002;1229-1232.
41. Grabsch H., Takeno S., Parsons W.J., Pomjanski N., Boecking A., Gabbert H.E., Mueller W. Overexpression of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in gastric cancer - association with tumour cell proliferation. J. Pathol. 200:2003;16-22.
42. Myrie K.A., Percy M.J., Azim J.N., Neeley C.K., Petty E.M. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett. 152:2000;193-199.
43. Shigeishi H., Oue N., Kuniyasu H., Wakikawa A., Yokozaki H., Ishikawa T., Yasui W. Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas. Pathobiology. 69:2001;24-29.
44. Chiba S., Okuda M., Mussman J.G., Fukasawa K. Genomic convergence and suppression of centrosome hyperamplification in primary p53-/- cells in prolonged culture. Exp. Cell Res. 258:2000;310-321.
45. Heim S., Mandahl N., Mitelman F. Genetic convergence and divergence in tumor progression. Cancer Res. 48:1988;5911-5916.
46. Jin C., Jin Y.S., Wennerberg J., Akervall J., Dictor M., Mandahl N., Heim S., Mitelman F., Mertens F. Cytogenetic analysis of inverted nasal papillomas and demonstration of genetic convergence during in vitro passaging. Int. J. Cancer. 70:1997;668-673.
47. Heim S., Caron M., Jin Y., Mandahl N., Mitelman F. Genetic convergence during serial in vitro passage of a polyclonal squamous cell carcinoma. Cytogenet. Cell Genet. 52:1989;133-135.
48. Concannon C.G., Gorman A.M., Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis. 8:2003;61-70.
49. Wataba K., Saito T., Fukunaka K., Ashihara K., Nishmura M., Kudo R. Over-expression of heat shock proteins in carcinogenic endometrium. Int. J. Cancer. 91:2001;448-456.
50. Kapranos N., Kominea A., Konstantinopoulos P.A., Savva S., Artelaris S., Vandoros G., Sotiropoulou-Bonikou G., Papavassiliou A.G. Expression of the 27. kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance J. Cancer Res. Clin. Oncol. 128:2002;426-432.
51. Lambot M.A., Peny M.O., Fayt I., Haot J., Noel J.C. Overexpression of 27. kDa heat shock protein relates to poor histological differentiation in human oesophageal squamous cell carcinoma Histopathology. 36:2000;326-330.
52. Leonardi R., Pannone G., Magro G., Kudo Y., Takata T., Muzio L.L. Differential expression of heat shock protein 27 in normal oral mucosa, oral epithelial dysplasia and squamous cell carcinoma. Oncol. Rep. 9:2002;261-266.
53. Garrido C., Fromentin A., Bonnotte B., Favre N., Moutet M., Arrigo A.P., Mehlen P., Solary E. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res. 58:1998;5495-5499.
54. Lemieux P., Oesterreich S., Lawrence J.A., Steeg P.S., Hilsenbeck S.G., Harvey J.M., Fuqua S.A.W. The small heat shock protein hsp 27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis. 17:1997;113-123.
55. Katoh M., Koninkx J., Schumacher U. Heat shock protein expression in human tumours grown in severe combined immunodeficient mice. Cancer Lett. 161:2000;113-120.